Bellevue Asset Management’s AbbVie ABBV Stock Holding History

Bellevue Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.97K	Hold	35	–	–	﹤0.01%	305
2026 Q1	$7.69K	Hold	35	–	–	﹤0.01%	297
2025 Q4	$8.02K	Buy	35 +1	+3%	+$228	﹤0.01%	298
2025 Q3	$8.07K	Hold	34	–	–	﹤0.01%	300
2025 Q2	$6.42K	Hold	34	–	–	﹤0.01%	314
2025 Q1	$7.18K	Buy	34 +1	+3%	+$194	﹤0.01%	297
2024 Q4	$6.04K	Hold	33	–	–	﹤0.01%	324
2024 Q3	$6.64K	Hold	33	–	–	﹤0.01%	292
2024 Q2	$5.73K	Hold	33	–	–	﹤0.01%	305
2024 Q1	$6.02K	Buy	33 +1	+3%	+$172	﹤0.01%	292
2023 Q4	$5.08K	Hold	32	–	–	﹤0.01%	303
2023 Q3	$4.83K	Hold	32	–	–	﹤0.01%	294
2023 Q2	$4.33K	Buy	32 +1	+3%	+$147	﹤0.01%	322
2023 Q1	$5.07K	Hold	31	–	–	﹤0.01%	314
2022 Q4	$5.06K	Hold	31	–	–	﹤0.01%	311
2022 Q3	$4K	Buy	31 +1	+3%	+$143	﹤0.01%	319
2022 Q2	$5K	Hold	30	–	–	﹤0.01%	318
2022 Q1	$5K	Hold	30	–	–	﹤0.01%	348
2021 Q4	$4K	Buy	+30	New	+$3.54K	﹤0.01%	393

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bellevue Asset Management's ABBV Position: Q2 2026 in Review

Bellevue Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 35 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Bellevue Asset Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bellevue Asset Management held 35 shares of AbbVie worth $8.97K as of Q2 2026.
Bellevue Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up ﹤0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #305 holding.
Bellevue Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.